Robert Stefanovich - 12 Mar 2026 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Financial Officer
Signature
/s/ Robert Stefanovich
Issuer symbol
CYRX
Transactions as of
12 Mar 2026
Net transactions value
-$322,330
Form type
4
Filing time
16 Mar 2026, 21:35:53 UTC
Previous filing
21 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STEFANOVICH ROBERT Chief Financial Officer C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD /s/ Robert Stefanovich 16 Mar 2026 0001247309

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise +87,188 +42% $1.87* 294,401 12 Mar 2026 Direct
transaction CYRX Common Stock Sale $300,386 -38,700 -13% $7.76 255,701 12 Mar 2026 Direct F1, F2
transaction CYRX Common Stock Award +27,413 +11% $0.000000* 283,114 14 Mar 2026 Direct F3
transaction CYRX Common Stock Sale $21,944 -2,743 -0.97% $8.00 280,371 16 Mar 2026 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Options to purchase common stock Options Exercise -87,188 -100% $0.000000* 0 12 Mar 2026 Common Stock 87,188 $1.87 Direct F5
transaction CYRX Stock Option (right to buy) Award +82,240 $0.000000* 82,240 14 Mar 2026 Common Stock 82,240 $8.60 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.
F3 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
F4 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F5 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
F6 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.

Remarks:

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.